Biotech news
Americas
IP services company Clarivate Analytics has acquired patent sequence information provider SequenceBase to expand its search and analysis capabilities for the life sciences IP market. 9 September 2019
Asia
Indian drugmaker Lupin and German pharma company Boehringer Ingelheim have formed an alliance to develop a therapy for patients with difficult-to-treat cancers. 5 September 2019
Pharma
CAR-T cells have achieved hugely-positive outcomes in treating forms of cancer that are otherwise difficult to treat. 5 September 2019
Americas
US-based Vertex Pharmaceuticals has announced it will pay $950 million to acquire Semma Therapeutics, a biotechnology company focused on researching a cure for Type 1 diabetes. 4 September 2019
Biotech
An alliance of companies that use gene-editing technologies has released a bioethical framework, as controversy over gene-editing continues. 3 September 2019
Pharma
Nicole Jadeja, the former co-head of life sciences at Fieldfisher, has joined Pinsent Masons as a partner in its London office. 3 September 2019
Biotech
For all the importance of the role of government and private sector bodies in the realisation of precision medicine, it’s important not to lose sight of the interests and concerns of those precision medicine intends to treat—the patients and public at large, write Daniel Lim and Anna Jackson of Kirkland & Ellis. 29 August 2019
Pharma
Biotech company Ionis Pharmaceuticals is to license its antisense medicines, used to treat people with chronic hepatitis B, to GlaxoSmithKline. 28 August 2019
Americas
Ireland-based Jazz Pharma has acquired Virginia-based Cavion in a deal that values the clinical-stage biotech company at up to $312.5 million. 14 August 2019
Americas
Bayer is set to acquire the rest of BlueRock Therapeutics, in a deal that values the Massachusetts-based cell therapy company at $1 billion. 9 August 2019